Introduction: Thiazolidinedione's are widely used synthetic antidiabetic agents. These agents affect the pumping power of heart muscle due to the formation of edema; limiting their usage in patients with congestive heart failure. The current study was aimed to perform in silico docking study of bioactive phytoconstituents from Cissus quadrangularis Linn. against the target Peroxisome proliferator-activated gamma (PPAR-γ). Materials and Methods: The docking study was performed by using AutoDock 4.2. The chemical constituents were retrieved from the PubChem database. The pharmacokinetic and toxicological parameters of each compound were predicted using PreADMET online server. The drug-likeness character of each compounds were predicted using Molsoft. Results: Quercetin scored highest drug-likeness character. Among the seven compounds, four compounds scored positive drug-likeness score. Qaudrangularin A showed highest binding affinity with the target protein. Discussion: All the compounds showed the binding affinity with the target protein suggesting that the compounds from Cissus quadrangularis can be utilized to target PPAR-γ in the management of diabetes. The study suggests supporting the current study by performing wet lab experiments.
INTRODUCTION
Diabetes mellitus is a metabolic disorder characterized by insulin resistance, defects in insulin secretion and high hepatic gluconeogenesis. 1 Peroxisome Proliferator Activated Receptor-gamma (PPAR-γ) regulates lipid and glucose metabolism. [2] [3] [4] [5] Thiazolidinedione compounds have a high affinity for the PPAR-γ receptors and used in the treatment of Diabetes Mellitus (DM). PPAR-γ agonist opposes the effect of TNF-α, improve the insulin resistance 6 and adiponectin level and insulin sensitivity. 7, 8 They also enhance the expression of a number of genes encoding proteins involved in glucose and lipid metabolism. 9 However the thiazolidinedione pharmacotherapy is associated with various side effects 4, 10 leading to the search of new molecules. Cissus quadrangularis L. belongs to the family Vitaceae. That contains polyphenols, flavonoids and stilbenes as active biomolecules. [11] [12] [13] Among them, Quadrangularin A, Kaempferol, Piceatannol, Resveratrol, Quercetin, Luteolin and Asarone are used in various medicinal purposes i.e. metabolic syndrome, weight loss, jaw fracture injuries and neuropharmacological effects. [13] [14] [15] [16] [17] According to a review of the literature, there is no evidence to show the binding affinity of biomolecules from Cissus quadrangularis with PPAR-γ. Hence current study includes in silico docking analysis of active biomolecules from Cissus quadrangularis against the PPAR-γ.
MATERIALS AND METHODS

Ligand Preparation
All wo-dimensional (2D) and three dimensional (3D) structures of seven ligands were retrieved from PubChem chemical database. Canonical SMILES of each ligand were also collected. Each ligand was viewed in Discovery studio 2017 and saved into the PDB format. All the ligand molecules were minimized using Marvin sketch mmff94 force field. 2D images of all the selected ligand are shown in Figure 1 .
Protein Preparation
Three-dimensional crystallographic structure of peroxisome proliferators-activated receptor-γ (PDB ID: 4Y29) was retrieved from Protein Data Bank (www.rcsb.org). Discovery Studio 2017 was used to remove the water molecules and heteroatoms. A pocket of protein was analyzed using castP, Procheck and quality of protein were assessed using Errat online server. The first Pocket of protein molecule was chosen to dock the ligand against the protein. The protein was viewed in Ramachandran plot to understand the phi and psi scatter of amino acid residues shown in Figure 2 .
Pharmacokinetic (ADME) and Toxicological Predictions ADME and toxicological parameters of bioactive molecules were predicted by online PreADMET server (http://preadmet.bmdrc.org). This PreADMET server calculates pharmacokinetic and toxicological parameters based on the structure of the compound as BBB (C brain / C blood ), human intestinal absorption (%) plasma protein binding (%), mutagenic and carcinogenic effects.
Drug likeness Score of Bioactive Phytoconstituents
Drug likeness of each compound was predicted via an online server, Molsoft (http://molsoft.com/mprop/) which is based on molecular weight, total number of hydrogen bond donors, the total number of hydrogen bond acceptors and logP.
Ligand-Protein Docking
The molecular docking was performed using AutoDock 4.2. The protein was added with hydrogen atoms and Kollman charges. The grid box was set and docking was carried using Lamarckian Algorithm. After docking the dlg file was used to identify the best pose of ligand based on the binding energy. Finally, the pose having lowest binding energy was selected to visualize the ligand-protein interaction.
RESULTS AND DISCUSSION
The current study was carried out to understand the drug-likeness character of phytoconstituents from Cissus quadrangularis and their binding affinity with PPAR-γ. The Lipinski Rule of five states that compounds have poor absorptivity and bioavailability if their molecular weight is > 500g/mol, >5 hydrogen bond donors, >5 log P and >10 hydrogen bond acceptors. 18 Among the selected compounds, Quercetin scored highest druglikeness score i.e. 0.93 and Quadrangularin A scored lowest i.e. 0.48. However, Quadrangularin A violated two rules of Lipinski of five based on its log P and number of hydrogen bond donor. Compounds Piceatannol, Resveratrol and Asarone scored non-drug-likeness character of -0.43, -0.94 and -1.72 respectively. Although they scored non-drug likeness character, they did not violate any Rule of five ( Table 1) . The ADMET parameters were predicted by PreAD-MET online server. All the seven compounds showed 60 to 100% of human intestinal absorption, 89 to 100% plasma protein binding, CYP2C19, CYP2C9 and CYP3A4 inhibition. All seven compounds were a mutagen and have a medium risk on hERG inhibition. Quadrangularin A and Asarone showed carcinogenicity in mice, whereas Quadrangularin A, Kaempferol, Quercetin, Luteolin and Asarone showed carcinogenicity in the rat. The pharmacokinetic and toxicological parameters of all seven compounds are shown in Table 2 .
In docking studies, Binding Energy (BE) of each bioactive molecule with the protein molecule was calculated by, BE = A + B + C -D where, A denotes desolvation energy +final intermolecular energy + hydrogen bonds + van der Walls energy + electrostatic energy, B denotes final total internal energy, C denotes torsional free energy and D denotes unbound system's energy. Among the selected compounds, Quadrangularin A showed the highest binding affinity with PPAR-γ whereas Asarone showed the least ( dues of protein molecule i.e. GLU A:324, SER A:394 via two bonds.
On comparing all seven compounds, Luteolin can be choice of compound to bind with the PPAR-γ receptor. This is because Quadrangularin A fails to obey the Rule of Five and Quercetin has a less binding affinity with PPAR-γ compared to Luteolin. Although the docking study of Piceatannol, Resveratrol and Asarone showed binding affinity with PPAR-γ, the compounds were rejected by Lipinski rule of five. Hence, these phytochemicals may not be considered as drug molecules. The binding energy of individual compounds with PPAR-γ is shown in Table 3 . The ligand parameters of individual molecules are shown in Table 4 . The interaction of each ligand with PPAR-γ is shown in Figure 3 . PPAR-γ agonist promotes adipogenesis and accelerates adipocytes differentiation by promoting the uptake of Free Fatty Acid (FFA) in subcutaneous adipose tissues. An agonist of PPAR-γ decreases circulating FFA and thereby decreases associated insulin resistance. 7 Com- parison of docked phytochemical constituents has a different binding affinity, hydrogen bond interaction and drug-likeness property. These chemical constituents may play important role in the regulation of PPAR-γ receptor and helpful in the treatment of diabetes mellitus.
CONCLUSION
The result obtained from the study confirms the hypothesis that seven chemical constituents of Cissus quadrangularis interact with the PPAR-γ receptor, may bring about the physiological changes in the patient suffering from diabetes mellitus. The binding energies of the proteinligand interactions also confirm that the ligand fit into the active pockets. Further in vitro and in vivo study of these phytoconstituents may replace the thiazolidinedione molecules could help in the development of novel anti-diabetic molecules. In the current study, six active biomolecules were screened against the PPAR-γ to assess the binding affinity, followed by the prediction of the ADMET. All the active biomolecules were predicted for the safety and efficacy under the various models to understand their pharmacokinetic and pharmacokinetic parameters. Toxicity of each compound was also predicted under various biological models. The outcome of the current study reflects to perform the wet lab experiments and the further confirmations are to be made via in vitro and in vivo studies. 
